Zdrowie i gospodarka · 17/02/2016

FDA Public Workshop on Point of Care Prothrombin Time/International Normalized Ratio Devices for Warfarin Therapy

The FDA is hosting a public workshop to discuss and gather input on point of care Prothrombin Time/International Normalized Ratio devices for monitoring warfarin therapy, with the goal of ensuring safety and effectiveness in clinical management of warfarin treatment.